Cargando…
Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial
INTRODUCTION: Efficacy of cryoballoon ablation depends on balloon‐tissue contact and ablation duration. Prolonged duration may increase extracardiac complications. The aim of this study is to determine the optimal additional ablation duration after acute pulmonary vein isolation (PVI). METHODS: Cons...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850340/ https://www.ncbi.nlm.nih.gov/pubmed/30884006 http://dx.doi.org/10.1111/jce.13913 |
_version_ | 1783469403374878720 |
---|---|
author | Keçe, Fehmi de Riva, Marta Naruse, Yoshihisa Alizadeh Dehnavi, Reza Wijnmaalen, Adrianus P. Schalij, Martin J. Zeppenfeld, Katja Trines, Serge A. |
author_facet | Keçe, Fehmi de Riva, Marta Naruse, Yoshihisa Alizadeh Dehnavi, Reza Wijnmaalen, Adrianus P. Schalij, Martin J. Zeppenfeld, Katja Trines, Serge A. |
author_sort | Keçe, Fehmi |
collection | PubMed |
description | INTRODUCTION: Efficacy of cryoballoon ablation depends on balloon‐tissue contact and ablation duration. Prolonged duration may increase extracardiac complications. The aim of this study is to determine the optimal additional ablation duration after acute pulmonary vein isolation (PVI). METHODS: Consecutive patients with paroxysmal AF were randomized to three groups according to additional ablation duration (90, 120, or 150 seconds) after acute PVI (time‐to‐isolation). Primary outcome was reconnection/dormant conduction (DC) after a 30 minutes waiting period. If present, additional 240 seconds ablations were performed. Ablations without time‐to‐isolation <90 seconds, esophageal temperature <18°C or decreased phrenic nerve capture were aborted. Patients were followed with 24‐hour Holter monitoring at 3, 6, and 12 months. RESULTS: Seventy‐five study patients (60 ± 11 years, 48 male) were included. Reconnection/DC per vein significantly decreased (22%, 6% and 4%) while aborted ablations remained stable (respectively 4, 5, and 7%) among the 90, 120, and 150 seconds groups. A shorter cryo‐application time, longer time‐to‐isolation, higher balloon temperature and unsuccessful ablations predicted reconnection/DC. Freedom of atrial fibrillation was, respectively, 52, 56, and 72% in 90, 120, and 150 seconds groups ( P = 0.27), while repeated procedures significantly decreased from 36% to 4% ( P = 0.041) in the longer duration group compared to shorter duration group (150 seconds vs 90 seconds group). In multivariate Cox‐regression only reconnection/DC predicted recurrence. CONCLUSION: Prolonging ablation duration after time‐to‐isolation significantly decreased reconnection/DC and repeated procedures, while recurrences and complications rates were similar. In a time‐to‐isolation approach, an additional ablation of 150 seconds ablation is the most appropriate. |
format | Online Article Text |
id | pubmed-6850340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68503402019-11-18 Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial Keçe, Fehmi de Riva, Marta Naruse, Yoshihisa Alizadeh Dehnavi, Reza Wijnmaalen, Adrianus P. Schalij, Martin J. Zeppenfeld, Katja Trines, Serge A. J Cardiovasc Electrophysiol Original Articles INTRODUCTION: Efficacy of cryoballoon ablation depends on balloon‐tissue contact and ablation duration. Prolonged duration may increase extracardiac complications. The aim of this study is to determine the optimal additional ablation duration after acute pulmonary vein isolation (PVI). METHODS: Consecutive patients with paroxysmal AF were randomized to three groups according to additional ablation duration (90, 120, or 150 seconds) after acute PVI (time‐to‐isolation). Primary outcome was reconnection/dormant conduction (DC) after a 30 minutes waiting period. If present, additional 240 seconds ablations were performed. Ablations without time‐to‐isolation <90 seconds, esophageal temperature <18°C or decreased phrenic nerve capture were aborted. Patients were followed with 24‐hour Holter monitoring at 3, 6, and 12 months. RESULTS: Seventy‐five study patients (60 ± 11 years, 48 male) were included. Reconnection/DC per vein significantly decreased (22%, 6% and 4%) while aborted ablations remained stable (respectively 4, 5, and 7%) among the 90, 120, and 150 seconds groups. A shorter cryo‐application time, longer time‐to‐isolation, higher balloon temperature and unsuccessful ablations predicted reconnection/DC. Freedom of atrial fibrillation was, respectively, 52, 56, and 72% in 90, 120, and 150 seconds groups ( P = 0.27), while repeated procedures significantly decreased from 36% to 4% ( P = 0.041) in the longer duration group compared to shorter duration group (150 seconds vs 90 seconds group). In multivariate Cox‐regression only reconnection/DC predicted recurrence. CONCLUSION: Prolonging ablation duration after time‐to‐isolation significantly decreased reconnection/DC and repeated procedures, while recurrences and complications rates were similar. In a time‐to‐isolation approach, an additional ablation of 150 seconds ablation is the most appropriate. John Wiley and Sons Inc. 2019-03-29 2019-06 /pmc/articles/PMC6850340/ /pubmed/30884006 http://dx.doi.org/10.1111/jce.13913 Text en © 2019 The Authors. Journal of Cardiovascular Electrophysiology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Keçe, Fehmi de Riva, Marta Naruse, Yoshihisa Alizadeh Dehnavi, Reza Wijnmaalen, Adrianus P. Schalij, Martin J. Zeppenfeld, Katja Trines, Serge A. Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial |
title | Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial |
title_full | Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial |
title_fullStr | Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial |
title_full_unstemmed | Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial |
title_short | Optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: A randomized controlled trial |
title_sort | optimizing ablation duration using dormant conduction to reveal incomplete isolation with the second generation cryoballoon: a randomized controlled trial |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850340/ https://www.ncbi.nlm.nih.gov/pubmed/30884006 http://dx.doi.org/10.1111/jce.13913 |
work_keys_str_mv | AT kecefehmi optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial AT derivamarta optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial AT naruseyoshihisa optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial AT alizadehdehnavireza optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial AT wijnmaalenadrianusp optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial AT schalijmartinj optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial AT zeppenfeldkatja optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial AT trinessergea optimizingablationdurationusingdormantconductiontorevealincompleteisolationwiththesecondgenerationcryoballoonarandomizedcontrolledtrial |